LifeVantage Corporation LFVN NASDAQ · Consumer defensive · United States
$4.89 +1.66% +$0.08
Summary
63 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 26% a year over the last 3 years.
- It holds more cash than debt: $13.7M against $9.40M.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $2.04M in the last fiscal year, 3.3% of its market value.
What to watch
- Revenue fell by 5.1% a year over the last 3 years.
- Out of every 100 USD of revenue, only 1.6 USD is left as net profit.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 22.8 USD for 1 USD of yearly profit. Over the last five years it was 20.2 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 3.7% a year over 5 years. Over the last 3 years it fell by 5.1% a year. Earnings per share grew by 26% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 23 USD
- Sales and administration 74 USD
- Taxes and other 0.6 USD
- Net profit 1.6 USD
Net profit, industry median (Packaged Foods) 5.4 USD
Out of every 100 USD of revenue, 1.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.1 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.89%
- Paid out of profit
- 89%
- Raised in a row
- 3 years
You receive $0.19 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $6 is 23% above today's price. 33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Protandim 95%
- Product and Service, Other 5.1%
By region
- UNITED STATES 59%
- Non-US 21%
- JAPAN 11%
- Other Foreign 10%
Protandim brings in 95% of revenue.
Segments in detail